Resonant Capital Advisors »

Intellia Therapeutics shares owned by Resonant Capital Advisors

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Resonant Capital Advisors from 13F filings

Historical chart of Resonant Capital Advisors investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Resonant Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Resonant Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $922k 41k 22.38
2024-03-31 $1.1M 42k 27.51
2023-12-31 $1.3M 41k 30.49
2023-09-30 $989k 31k 31.62

More positions owned by Resonant Capital Advisors

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr 0-3 Mnth Treasry (SGOV)
J P Morgan Exchange Traded F Ultra Sht Muncpl (JMST)
Ishares U S Etf Tr Blackrock Short (MEAR)
Etf Ser Solutions Distillate Us (DSTL)
Vanguard Specialized Funds Div App Etf (VIG)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Core S&p Mcp Etf (IJH)
Schwab Strategic Tr Fundamental Us L (FNDX)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Fundamental Us S (FNDA)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Resonant Capital Advisors

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
BlackRock
Vanguard Group
Deep Track Capital
State Street Corporation
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Federated Investors
Geode Capital Management
Morgan Stanley
Contrarius Investment Management
Casdin Capital
Alliancebernstein
Dimensional Fund Advisors

View all funds holding Intellia Therapeutics